Global Therapeutic Vaccines Market 2014-2018

Global Therapeutic Vaccines Market 2014-2018

Category : Pharmaceuticals
Published On : March  2014
Pages : 54

------------ Or -------------

About Therapeutic Vaccines
A therapeutic vaccine is a biological combination developed to improve immunity by inducing an attack against a diseased cell or tissue. This differs from prophylactic vaccines, which are administered to an individual with a disease in order to induce a defense mechanism. There are two approved cancer therapeutic vaccines on the market; Provenge and Oncophage. Additionally, a large number of therapeutic vaccines are under clinical development and are expected to be approved for use during the forecast period.
TechNavio's analysts forecast the Global Therapeutic Vaccines market to grow at a CAGR of 62.81 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Therapeutic Vaccine market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various therapeutic vaccines available in the market.
TechNavio's report, the Global Therapeutic Vaccines Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Therapeutic Vaccines market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas 
• EMEA        
Key Vendors
• Agenus Inc. 
• Bavarian Nordic A/S.
• Dendreon Corp. 
• GlaxoSmithKline plc
• Novartis International AG
Other Prominent Vendors
• Argos Therapeutics Inc.
• Celldex Therapeutics Inc. 
• CEL-SCI Corp.
• Cytos Biotechnology AG
• GlobeImmune Inc.
• NewLink Genetics Corp.
• NovaRx Corp.
• Oncothyreon Inc.
• TVAX Biomedical Inc.
• TapImmune Inc.
• Vical Inc.
• Vaccinogen Inc. 

Market Driver
• Increase in Incidence of Cancer, Infectious Diseases, and Physiological Disorders
• Ongoing Development of a Large Number of Therapeutic Vaccines
Market Challenge
• Stringent Regulations
• Adverse Side Effects of Therapeutic Vaccines
Market Trend
• Improved Understanding of Immunology and Immunotherapy
• Increase in Mergers and Acquisitions
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Geographical Segmentation

08. Key Leading Countries

08.1 USA

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Pipeline Analysis

17. Vendor Landscape

17.1 Competitive Scenario

17.1.1 Key News

17.1.2 Mergers and Acquisitions

17.2 Other Prominent Vendors

18. Key Vendor Analysis

18.1 Agenus Inc.

18.1.1 Business Overview

18.1.2 Key Information

18.1.3 SWOT Analysis

18.2 Bavarian Nordic A/S

18.2.1 Business Overview

18.2.2 Business Segmentation

18.2.3 Key Information

18.2.4 SWOT Analysis

18.3 Dendreon Corp.

18.3.1 Business Overview

18.3.2 Key Information

18.3.3 SWOT Analysis

18.4 GlaxoSmithKline plc

18.4.1 Business Overview

18.4.2 Business Segmentation

18.4.3 Key Information

18.4.4 SWOT Analysis

18.5 Novartis International AG

18.5.1 Business Overview

18.5.2 Business Segmentation

18.5.3 Key Information

18.5.4 SWOT AnalysisOther Reports in the Series

List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Global Therapeutic Vaccines Market 2013-2018 (US$ billion)

Exhibit 3: Global Therapeutic Vaccines Market by Geographical Segmentation 2013

Exhibit 4: Segmentation of Therapeutic Vaccines under Clinical Trial, by Disease 2013

Exhibit 5: Segmentation of Therapeutic Vaccines under Clinical Trial by Type of Cancer 2013

Exhibit 6: Segmentation of Therapeutic Vaccines under Clinical Trial by Type of Tropical Infectious Disease 2013

Exhibit 7: Segmentation of Therapeutic Vaccines under Clinical Trial, By Physiological Disorders 2013

Exhibit 8: Late Stage Pipeline Analysis of Therapeutic Vaccines 2013

Exhibit 9: Business Segmentation of Bavarian Nordic A/S

Exhibit 10: Business Segmentation of GlaxoSmithKline plc

Exhibit 11: Business Segmentation of Novartis International AG

Enquiry Before Buy